Paratek Pharmaceuticals, Inc.

PRTK · NASDAQ
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Assets
Cash & Equivalents$34,248$80,367$105,157$102,302
Short-Term Investments$0$15,107$20,005$113,077
Receivables$78,038$33,117$15,733$9,583
Inventory$16,565$11,020$14,555$11,579
Other Curr. Assets$7,991$12,489$8,667$6,813
Total Curr. Assets$136,842$152,100$164,117$243,354
Property Plant & Equip (Net)$2,398$2,551$2,974$3,741
Goodwill$829$829$829$829
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$32,469$28,389$8,933$3,155
Total NC Assets$35,696$31,769$12,736$7,725
Other Assets$0$0$0$0
Total Assets$172,538$183,869$176,853$251,079
Liabilities
Payables$5,308$5,394$1,813$4,116
Short-Term Debt$0$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$32,080$25,903$22,140$20,084
Total Curr. Liab.$37,388$31,297$23,953$24,200
LT Debt$258,414$255,736$252,018$262,823
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$47,778$24,623$3,142$3,703
Total NC Liab.$306,192$280,359$255,160$266,526
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$343,580$311,656$279,113$290,726
Equity
Pref Stock$0$0$0$0
Common Stock$56$52$705,535$671,537
Retained Earnings-$930,449-$866,883-$807,799-$711,258
AOCI$0-$9$4$74
Other Equity$759,351$739,053-$4-$74
Total Equity-$171,042-$127,787-$102,264-$39,721
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$172,538$183,869$176,849$251,005
Net Debt$224,166$175,369$146,861$160,521